E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Return
36.19%
This Quarter Return
+13.35%
1 Year Return
+36.19%
3 Year Return
+76.51%
5 Year Return
–
10 Year Return
–
AUM
$2.72B
AUM Growth
-$123M
(-4.3%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-7.86%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
+$87.2M |
| 2 |
Steel Dynamics
STLD
|
+$51M |
| 3 |
McKesson
MCK
|
+$43.9M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$38.5M |
| 5 |
Arch Capital
ACGL
|
+$29.3M |
Top Sells
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$149M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$147M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$44.3M |
| 4 |
CoStar Group
CSGP
|
+$44.2M |
| 5 |
Chevron
CVX
|
+$43.8M |
Sector Composition
| 1 | Financials | 15.28% |
| 2 | Healthcare | 12.36% |
| 3 | Industrials | 12.2% |
| 4 | Technology | 10.36% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Candel Therapeutics
CADL
$270M
| $46.7K | ﹤0.01% |
+26,114
| New | +$46.7K |
|
1302
Glimpse Group
VRAR
$31M
| $46.7K | ﹤0.01% |
+15,422
| New | +$46.7K |
|
1303
AquaBounty Technologies
AQB
$4.46M
| $45.3K | ﹤0.01% |
2,964
-9,689
| -77% | -$148K |
|
1304
Karyopharm Therapeutics
KPTI
$57.6M
| $45.3K | ﹤0.01% |
+888
| New | +$45.3K |
|
|
TCRR
1305
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $45.1K | ﹤0.01% |
45,150
-65,519
| -59% | -$65.4K |
|
|
AWH
1306
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $44.9K | ﹤0.01% |
8,998
-10,226
| -53% | -$51K |
|
1307
Tourmaline Bio
TRML
$1.22B
| $44.4K | ﹤0.01% |
+4,352
| New | +$44.4K |
|
|
NAGE
1308
Niagen Bioscience, Inc. Common Stock
NAGE
$767M
| $44K | ﹤0.01% |
26,170
-101,041
| -79% | -$170K |
|
1309
Elicio Therapeutics
ELTX
$189M
| $42.9K | ﹤0.01% |
5,291
-2,595
| -33% | -$21.1K |
|
|
SURF
1310
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $42.8K | ﹤0.01% |
+52,234
| New | +$42.8K |
|
|
ROVR
1311
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $42.8K | ﹤0.01% |
+11,649
| New | +$42.8K |
|
1312
SelectQuote
SLQT
$363M
| $41.3K | ﹤0.01% |
+61,533
| New | +$41.3K |
|
1313
Curis
CRIS
$22.7M
| $41.2K | ﹤0.01% |
3,749
-2,466
| -40% | -$27.1K |
|
1314
Compugen
CGEN
$131M
| $40.9K | ﹤0.01% |
+57,181
| New | +$40.9K |
|
1315
Sky Harbour Group
SKYH
$344M
| $40.9K | ﹤0.01% |
15,360
-2,953
| -16% | -$7.86K |
|
|
CLLS
1316
Cellectis
CLLS
$299M
| $40.7K | ﹤0.01% |
+19,365
| New | +$40.7K |
|
|
INFI
1317
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $38.7K | ﹤0.01% |
69,660
-338,754
| -83% | -$188K |
|
|
CNTB
1318
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$90.8M
| $38.4K | ﹤0.01% |
+44,297
| New | +$38.4K |
|
1319
Bolt Biotherapeutics
BOLT
$10.1M
| $37.1K | ﹤0.01% |
1,425
-2,984
| -68% | -$77.6K |
|
1320
Black Diamond Therapeutics
BDTX
$192M
| $36.4K | ﹤0.01% |
20,212
-30,135
| -60% | -$54.2K |
|
1321
Aligos Therapeutics
ALGS
$75.6M
| $34.7K | ﹤0.01% |
1,455
-661
| -31% | -$15.7K |
|
1322
Armata Pharmaceuticals
ARMP
$107M
| $34.6K | ﹤0.01% |
+27,941
| New | +$34.6K |
|
1323
Rapid Micro Biosystems
RPID
$130M
| $34.5K | ﹤0.01% |
30,574
-38,859
| -56% | -$43.9K |
|
1324
Satellogic
SATL
$395M
| $34.4K | ﹤0.01% |
11,000
| – | – |
|
1325
Biodesix
BDSX
$60.6M
| $33.7K | ﹤0.01% |
+14,664
| New | +$33.7K |
|